- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03447418
Multiple Breath Nitrogen Washout in Healthy Volunteers (HV-LCI)
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bron, France
- Recruiting
- Hopital Femme Mere Enfant
-
Contact:
- Philippe REIX, Pr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Informed consent by participant, parent, or legal guardian
- Healthy subjects with a social insurance
Exclusion Criteria:
- History of a lung chronic disease
- Premature birth (<37th weeks of amenorrhea)
- Acute lower respiratory viral infection within 3 weeks before Multiple Breath washout
Study Plan
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
OTHER: no treatment, open label
|
Lung Clearance Index (LCI) will be performed in healthy volunteers with a multiple breath nitrogen washout device.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Lung Clearance Index 2.5% (LCI 2.5%) Value
Time Frame: hour 1
|
Multiple breath washout is a pulmonary function test that does not require patients' cooperation. It studies the number of lung volumes (turn-over) to clear a gaz such as nitrogen form the lungs. LCI 2,5 is most frequently reported outcome measure. It corresponds to the sum of the total expired lung volumes needed to decrease the initial gaz concretion to its 1/40th, divided by functional residual capacity. LCI can be measured in infant, preschoolers and thereafter. In order to obtain reproducible tests, three acceptable maneuvers are needed. |
hour 1
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Lung Clearance Index 5% (LCI 5%) Value
Time Frame: hour 1
|
hour 1
|
|
|
Moment ratio M1/M0 Value
Time Frame: up to 1 hour
|
up to 1 hour
|
|
|
Moment ratio M0/M2 Value
Time Frame: up to 1 hour
|
up to 1 hour
|
|
|
Sacin value
Time Frame: hour 1
|
assessment of distal areas function
|
hour 1
|
|
Scond value
Time Frame: hour 1
|
assessment of conductive areas function
|
hour 1
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 69HCL18_0064
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
University of Vermont Medical CenterAvocado Nutrition CenterRecruitingHealthy | Healthy Volunteers | Healthy Subjects | Healthy Volunteer | Healthy Adult | Healthy Volunteers Only | Healthy Male and Female Subjects | Healthy Non-smokersUnited States
-
Dragonfly TherapeuticsRecruitingHealthy | Healthy Participants | Healthy Adult Females | Volunteer | Healthy Adult MaleAustralia
-
University of PalermoCompletedHealthy | Healthy Volunteers | Healthy Subjects | Healthy Participants | Static Stretching | Stretch | StretchingItaly
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Umm Al-Qura UniversityActive, not recruitingHealthy | Healthy Participants | Healthy Adult | Healthy Women | Healthy Adult Females | Healthy Adult Participants | Healthy Young Adults | Healthy Adult Female Participants | Healthy Adult Male | Poor Sleep Quality | Healthy (Controls) | Poor Sleeping Quality | Healthy Adult Male Subjects | Health Adult SubjectsSaudi Arabia
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
University of PalermoCompletedHealthy Participants | Healthy Adult Participants | Healthy Young AdultsItaly
-
PfizerNot yet recruitingHealthy | Healthy AdultsUnited States
-
RAGE BioRecruitingHealthy | Healthy SmokerAustralia
Clinical Trials on Multiple breath nitrogen washout
-
Universitair Ziekenhuis BrusselVrije Universiteit BrusselRecruiting
-
Universitair Ziekenhuis BrusselTerminatedBronchiectasis | Asthma | Cystic FibrosisBelgium
-
Wissenschaftliches Institut Bethanien e.VBoehringer Ingelheim; ndd Medizintechnik AGCompletedAsthma | Pulmonary Fibrosis | COPDGermany
-
Universitätsmedizin MannheimUnknownPulmonary Disease | Pulmonary Healthy ControlsGermany
-
University of ZurichRecruitingChronic Rejection of Lung TransplantSwitzerland
-
Universitätsmedizin MannheimCompletedChronic Obstructive Pulmonary Disease | Sarcoidosis | Bronchial Asthma | Healthy Controls
-
University Hospital Inselspital, BerneLindenhofspitalCompletedDeath | Cystic Fibrosis | Lung TransplantationSwitzerland
-
Universitätsmedizin MannheimCompletedPulmonary Hypertension
-
Universitätsmedizin MannheimUnknownPulmonary Emphysema | COPD | Obstructive Ventilation DisorderGermany
-
Universitätsmedizin MannheimUnknownIdiopathic Pulmonary Fibrosis | Interstitial Lung Disease | Sarcoidosis | Pulmonary Healthy Controls | Non-specific Interstitial Pneumonia | Granulomatosis With Polyangiitis (Wegener's Disease)Germany